서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Publisher

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 10 of 10

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2009-08	Degradable polyethylenimines as DNA and small interfering RNA carriers Jere, D.; Jiang, H. L.; Arote, R.; Kim, Y. K.; Choi, Y. J.; Cho, M. H.; Akaike, T.; Chot, C. S. Expert Opinion on Drug Delivery, Vol.6 No.8, pp.827-834	DOI
2011-09	Degradable poly(amido amine)s as gene delivery carriers Arote, Rohidas B.; Jiang, Hu-Lin; Kim, You-Kyoung; Cho, Myung-Haing; Choi, Yun-Jaie; Cho, Chong-Su Expert Opinion on Drug Delivery, Vol.8 No.9, pp.1237-1246	DOI
2013-03	Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Chow, Louis W. C.; Tung, Stewart Y.; Ng, Ting-Ying; Im, Seock-Ah; Lee, Min-Hyuk; Yip, Adrian Y. S.; Toi, Masakazu; Glueck, Stefan Expert Opinion on Investigational Drugs, Vol.22 No.3, pp.299-307	DOI
2015-06	Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy Hong, Seong-Ho; Park, Sung-Jin; Lee, Somin; Cho, Chong Su; Cho, Myung-Haing Expert Opinion on Drug Delivery, Vol.12 No.6, pp.977-991	DOI
2016-02	Pertuzumab in gastrointestinal cancer Oh, Do-Youn; Bang, Yung-Jue Expert Opinion on Biological Therapy, Vol.16 No.2, pp.243-253	DOI
2019-07	Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy Lee, Ah Young; Cho, Myung-Haing; Kim, Sanghwa Expert Opinion on Drug Delivery, Vol.16 No.7, pp.757-772	DOI
2019-08	Tumor-targeting glycol chitosan nanocarriers: Overcoming the challenges posed by chemotherapeutics Choi, Yongwhan; Lim, Seungho; Yoon, Hong Yeol; Kim, Byung-Soo; Kwon, Ick Chan; Kim, Kwangmeyung Expert Opinion on Drug Delivery, Vol.16 No.8, pp.835-846	DOI
2019-11	Comparative and quantitative assessment on statin efficacy and safety: insights into inter-statin and inter-individual variability via dose- and exposure-response relationships Iwaki, Yuki; Lee, Wooin; Sugiyama, Yuichi Expert Opinion on Drug Metabolism and Toxicology, Vol.15 No.11, pp.897-911	DOI
2022-07	A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer Cho, Byoung Chul; Goldberg, Sarah B.; Kim, Dong-Wan; Socinski, Mark A.; Burns, Timothy F.; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C.; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim Expert Opinion on Investigational Drugs, Vol.31 No.7, pp.747-757
2022-11	Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension Chang, Sung-A; Lee, Sang Hyun; Choi, Jung Hyun; Chung, Wook-Jin; Choi, Jae Young; Kim, Hyung-Kwan; Jung, Hae-Ok; Park, Seong-Mi; Kim, Won-Jang; Jung, Su Young; Chang, Hyuk-Jae Expert Opinion on Drug Safety, Vol.21 No.11, pp.1423-1432	DOI

1